[Action of a novel anti-inflammatory agent: 804 CB on Masugi type experimental glomerulonephritis].
D000818:Animals; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D000918:Antibody Specificity; D003165:Complement System Proteins; D003510:Cyclohexanes / Q000627:therapeutic use; D004372:Ducks / Q000276:immunology; D005921:Glomerulonephritis / Q000188:drug therapy* / Q000276:immunology / Q000473:pathology; D006417:Hematuria / Q000188:drug therapy; D007106:Immune Sera; D007114:Immunization; D007651:Keto Acids / Q000627:therapeutic use; D007668:Kidney / Q000276:immunology / Q000473:pathology; D010654:Phenylbutyrates / Q000627:therapeutic use*; D011507:Proteinuria / Q000188:drug therapy; D011817:Rabbits; D013997:Time Factors
D000893:Anti-Inflammatory Agents; D003510:Cyclohexanes; D007106:Immune Sera; D007651:Keto Acids; D010654:Phenylbutyrates; D003165:Complement System Proteins
Action d'un nouvel anti-inflammatoire: 804 CB sur la glomérulo-néphrite expérimentale type Masugi